ECoG for Motor and Speech Control (BRAVO)
Study Purpose:
Test the feasibility of using electrocorticography (ECoG) signals to control complex devices for motor and speech control in adults severely affected by neurological disorders.
Disease:
Amyotrophic Lateral Sclerosis (ALS), Familial ALS, Sporadic ALS, Primary Lateral Sclerosis (PLS),Study Type:
Interventional TrialStudy Category:
DeviceStudy Status:
EnrollingPhase:
Not ApplicableStudy Chair(s)/Principal Investigator(s):
Karunesh Ganguly, MD, PhD University of California, San Francisco
Edward Chang, MD University of California, San Francisco
Clinicaltrials.gov ID (11 digit #):
NCT03698149Neals Affiliated?
NoCoordinating Center Contact Information
University of California, San FranciscoAdelyn Tu-Chan / .(JavaScript must be enabled to view this email address) / (415) 575-0431
.(JavaScript must be enabled to view this email address) 505 Parnassus Ave
San Francisco, California 94158 United States
Full Study Summary:
ECoG is a type of electrophysiological monitoring that uses electrodes placed directly on the exposed surface of the brain to record electrical activity. With this ECoG-based neural interface, study patients will undergo training and assessment of their ability to control a complex robotic system and to determine if ECoG brain signals can be used to produce speech.